171 related articles for article (PubMed ID: 8435802)
1. Phase II trial of carboplatin and etoposide in metastatic breast cancer.
Crown J; Hakes T; Reichman B; Lebwohl D; Gilewski T; Surbone A; Currie V; Yao TJ; Hudis C; Seidman A
Cancer; 1993 Feb; 71(4):1254-7. PubMed ID: 8435802
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
3. Phase II evaluation of carboplatin and VP-16 for patients with metastatic breast cancer and only one prior chemotherapy regimen.
Barker LJ; Jones SE; Savin MA; Mennel RG
Cancer; 1993 Aug; 72(3):771-3. PubMed ID: 8334629
[TBL] [Abstract][Full Text] [Related]
4. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
6. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
[TBL] [Abstract][Full Text] [Related]
7. Phase II and III studies with carboplatin in small cell lung cancer.
Gatzemeier U; Hossfeld DK; Neuhauss R; Reck M; Achterrath W; Lenaz L
Semin Oncol; 1992 Feb; 19(1 Suppl 2):28-36. PubMed ID: 1329220
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin/etoposide in small cell lung cancer.
Bishop JF
Oncology; 1992; 49 Suppl 1():11-7; discussion 17-8. PubMed ID: 1323807
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study.
Deltetto F; Durando A; Camanni M; Pesola D; Sberveglieri M; Arese P; Massobrio M
Eur J Gynaecol Oncol; 1997; 18(3):185-7. PubMed ID: 9174832
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870
[TBL] [Abstract][Full Text] [Related]
12. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
[TBL] [Abstract][Full Text] [Related]
13. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
Nichols CR; Tricot G; Williams SD; van Besien K; Loehrer PJ; Roth BJ; Akard L; Hoffman R; Goulet R; Wolff SN
J Clin Oncol; 1989 Jul; 7(7):932-9. PubMed ID: 2544687
[TBL] [Abstract][Full Text] [Related]
14. High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Nagasawa S
Cancer; 1994 Mar; 73(6):1678-85. PubMed ID: 7512436
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
[TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.
van der Gaast A; Bontenbal M; Planting AS; Kok TC; Splinter TA
Ann Oncol; 1994 Nov; 5(9):858-60. PubMed ID: 7661927
[TBL] [Abstract][Full Text] [Related]
18. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin in small cell lung cancer: the Royal Marsden Hospital experience.
Smith IE
Semin Oncol; 1992 Feb; 19(1 Suppl 2):24-7. PubMed ID: 1384136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]